Every person walking the planet carries roughly 37 trillion cells, and nearly every one of those cells holds an identical copy of that individual’s DNA. That number, once loosely pegged at 10 trillion, has been revised upward over the past decade by successive peer-reviewed studies. The revisions have quietly reshaped how researchers think about the human body’s relationship with its resident bacteria, with direct consequences for how microbiome studies are designed and interpreted.
Why the 37 Trillion Cell Count Changes the Microbiome Debate
For years, popular science writing repeated a striking claim: bacterial cells in the human body outnumber human cells by a factor of ten to one. That ratio was built on an older estimate that placed human cell totals at roughly 10 trillion. A government-hosted explainer on the National Library of Medicine site traces the correction, noting that the outdated figure inflated the perceived microbial dominance. When researchers recalculated human cell totals upward to 30 trillion or more, the dramatic ten-to-one ratio collapsed.
The practical fallout is real. If human cells and bacterial cells exist in roughly equal numbers rather than at a ten-to-one deficit, the baseline assumptions behind microbiome intervention trials shift. Trials that measure changes in bacterial load relative to host cells need accurate denominators. Distinguishing nucleated cells, which carry DNA, from non-nucleated cells like mature red blood cells alters those denominators further. Refining how scientists weight these two populations could change bacterial-to-human ratios enough to force design adjustments in clinical studies over the next several years.
Competing Estimates From Bianconi, Sender, and NIH Programs
Two primary studies anchor the modern consensus, though they do not agree on a single number. Bianconi and colleagues, publishing in the Annals of Human Biology in 2013, aggregated cell counts across organs and cell types and arrived at about 3.72 × 10^13 human cells, often rounded to 37 trillion. Three years later, Sender and co-authors revisited those totals in PLOS Biology and proposed a lower figure of roughly 3.0 × 10^13 cells for a 70‑kilogram reference man, while estimating bacterial cells at about 3.8 × 10^13. The gap between 30 trillion and 37 trillion may sound small, but it represents trillions of cells and reflects genuine uncertainty about which tissues and cell types to include.
A 2023 synthesis in the Proceedings of the National Academy of Sciences surveyed tissue-by-tissue data and found that recent estimates converge on a range of 30 to 37 trillion human cells, with the spread depending partly on whether non-nucleated cells are counted. Blood cells dominate the total count by sheer number, and because blood volume and body size differ among individuals, the total number of cells scales accordingly. Males tend to carry more total cells than females, largely because of greater average body mass, but those sex-based differences sit inside a broader spectrum that also reflects height, adiposity, and hydration status.
Large-scale mapping projects have adopted these updated figures as working baselines rather than fixed truths. The Human BioMolecular Atlas Program, for example, uses a 37 trillion–cell estimate to frame its effort to build a reference map of cell types and states in the adult body. Program documents emphasize that “how many cells” is only one dimension of the problem; equally important are where those cells reside, how they change over time, and how their molecular profiles vary between individuals.
The DNA Exception That Proves the Rule
The claim that nearly every cell carries the same DNA rests on a straightforward biological principle: nuclear DNA is copied during each cell division, so the genome in a skin cell is essentially identical to the genome in a neuron. That continuity underlies everything from forensic genetics to cancer diagnostics. Yet the qualifier “nearly” is crucial because some common cell types break the rule.
Fully differentiated red blood cells in humans eject their nuclei during maturation, leaving them without any nuclear DNA at all. Since red blood cells account for a substantial fraction of the total cell count, the number of cells that actually house a nuclear genome is meaningfully lower than the 30–37 trillion figure suggests. When researchers estimate how many copies of the nuclear genome are present in the body, they must strip red blood cells out of the tally and focus on nucleated cells in tissues such as muscle, liver, and the immune system.
Gametes-sperm and eggs-introduce a different twist. They carry only half the usual complement of chromosomes, reflecting their specialized role in reproduction. Mitochondria add another layer of complexity. These energy-producing organelles contain their own small genomes, and mitochondrial DNA copy number varies widely between cell types, with metabolically active tissues harboring many more copies per cell. As a result, the total number of mitochondrial genomes in the body can far exceed the number of nuclear genomes, even though both sets of DNA reside inside the same overall population of cells.
These distinctions matter when scientists try to connect cell counts to genomic data. Some widely cited educational materials still describe the body as having on the order of 10^13 cells, each containing its own copy or copies of the genome. That phrasing reflects an earlier era of cell-count estimates and does not fully align with the 30–37 trillion range supported by more recent work. The mismatch illustrates how quickly reference numbers can shift once researchers begin to compile more precise, tissue-specific measurements.
Open Questions About Cell Counts, Sex Differences, and Mapping
Several gaps in the evidence remain wide. No primary-source dataset currently provides individual-level cell counts broken down by age, disease state, ethnicity, or environmental exposure. Instead, most estimates rely on standardized “reference” bodies-typically a healthy adult of a specified sex and weight-and then extrapolate from organ volumes and typical cell densities. That approach is useful for building first-order models, but it inevitably blurs real-world variation.
Sex differences illustrate the problem. Analyses that start from average male and female body sizes suggest that males may carry tens of percent more total cells than females, driven mainly by larger blood volume and greater skeletal muscle mass. Yet those averages say little about a small-statured man compared with a tall, athletic woman, or about how chronic illness, pregnancy, or extreme training regimes might change cell totals and tissue composition. Without direct measurements, researchers must infer those shifts from indirect markers such as organ size on imaging scans or blood counts.
Age adds another dimension. Children have smaller bodies but proportionally larger organs such as the brain and thymus, while older adults may lose muscle mass and bone density over time. Each of those changes implies a different distribution of cell types, even if the overall cell count stays within the same order of magnitude. Longitudinal studies that track individuals across decades, combining imaging, blood analysis, and molecular profiling, could eventually refine how cell counts are modeled across the lifespan.
Mapping initiatives like HuBMAP and related cell atlas projects aim to close some of these gaps by cataloging cell types, states, and locations at high resolution. Their immediate focus is qualitative-what kinds of cells exist and where they reside-rather than providing precise per-person cell totals. Still, as these atlases accumulate data across tissues and demographics, they are likely to feed back into quantitative models, tightening the bounds on how many cells typical organs contain and how those numbers differ between people.
For microbiome science, genetics, and systems biology, the stakes are more than semantic. Whether the body holds 30 trillion or 37 trillion human cells changes how researchers normalize microbial loads, interpret sequencing readouts, and estimate how many cells must be targeted for a therapy to have systemic impact. The emerging consensus is that there is no single magic number, only a well-constrained range that continues to sharpen as new data arrive. In that sense, the evolving story of human cell counts is less about pinning down one final figure and more about building a framework flexible enough to accommodate the biological diversity that those trillions of cells represent.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
